Teladoc Health Sees Unusually Large Options Volume (NYSE:TDOC)

Teladoc Health, Inc. (NYSE:TDOC) saw unusually large options trading activity on Thursday. Stock traders purchased 33,742 call options on the stock. This is an increase of 66% compared to the typical daily volume of 20,354 call options.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in TDOC. Whipplewood Advisors LLC purchased a new stake in shares of Teladoc Health in the fourth quarter worth about $29,000. Versant Capital Management Inc lifted its position in Teladoc Health by 313.8% during the 4th quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider’s stock worth $29,000 after acquiring an additional 2,441 shares in the last quarter. Lindbrook Capital LLC lifted its position in Teladoc Health by 78.9% during the 4th quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider’s stock worth $33,000 after acquiring an additional 1,612 shares in the last quarter. Sterling Capital Management LLC boosted its holdings in Teladoc Health by 776.7% in the 4th quarter. Sterling Capital Management LLC now owns 4,629 shares of the health services provider’s stock worth $42,000 after acquiring an additional 4,101 shares during the period. Finally, Pilgrim Partners Asia Pte Ltd acquired a new stake in Teladoc Health in the fourth quarter valued at approximately $60,000. 76.82% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

TDOC has been the subject of a number of analyst reports. The Goldman Sachs Group cut their price objective on shares of Teladoc Health from $16.00 to $13.00 and set a “buy” rating for the company in a research report on Monday. Piper Sandler cut their price target on Teladoc Health from $13.00 to $12.00 and set an “overweight” rating for the company in a report on Thursday, February 27th. Royal Bank of Canada increased their price target on Teladoc Health from $11.00 to $12.00 and gave the stock an “outperform” rating in a research note on Friday, January 24th. Oppenheimer lowered their price objective on Teladoc Health from $14.00 to $12.00 and set an “outperform” rating for the company in a research report on Friday, January 24th. Finally, Bank of America increased their target price on Teladoc Health from $11.50 to $13.50 and gave the stock a “neutral” rating in a research report on Wednesday, February 12th. Eleven research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $11.26.

Teladoc Health Trading Up 3.7 %

NYSE TDOC opened at $9.37 on Friday. The firm has a market capitalization of $1.63 billion, a price-to-earnings ratio of -1.62 and a beta of 1.27. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73. Teladoc Health has a one year low of $6.76 and a one year high of $15.95. The company’s 50 day moving average price is $10.62 and its 200 day moving average price is $9.62.

Teladoc Health (NYSE:TDOC) last released its quarterly earnings data on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.21) by ($0.07). The business had revenue of $640.49 million during the quarter, compared to analyst estimates of $639.44 million. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. On average, sell-side analysts predict that Teladoc Health will post -1.16 EPS for the current year.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.